CG Oncology (CGON) Return on Capital Employed (2024 - 2026)
CG Oncology's (CGON) quarterly Return on Capital Employed came in at 23.16% in Q1 2026, down 446.0% YoY from 6.69% in Q1 2025, and up 11.39% on a QoQ basis from 26.14% in Q4 2025.
CG Oncology (CGON) Return on Capital Employed (2024 - 2026) Analysis & Trends
CG Oncology (CGON) has 3 years of Return on Capital Employed data on file, last reported at 23.16% in Q1 2026.
- Quarterly Return on Capital Employed fell 446.0% year-over-year to 23.16% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 23.16% (down 446.0% YoY) and the FY2025 annual result came in at 25.7%, down 53.0% from the prior year.
- Return on Capital Employed climbed to 23.16% in Q1 2026, from 26.14% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 14.6% in Q2 2024 to a low of 26.29% in Q3 2025.
- A 3-year average of 20.63% and a median of 18.7% in 2025 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 71 bps in 2025, down 861 bps in 2025.
- Tracing CGON's Return on Capital Employed over 3 years: stood at 18.14% in 2024, then sank by 44 bps to 26.14% in 2025, then advanced by 11 bps to 23.16% in 2026.
- The last three Return on Capital Employed figures came in at 23.16% (Q1 2026), 26.14% (Q4 2025), and 26.29% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -55.45% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.88% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 26.09% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -50.93% |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | -23.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.76% |
| Mar 31, 2026 | -23.16% |
| Dec 31, 2025 | -26.14% |
| Sep 30, 2025 | -26.29% |
| Jun 30, 2025 | -22.98% |
| Mar 31, 2025 | -18.70% |
| Dec 31, 2024 | -18.14% |
| Sep 30, 2024 | -17.68% |
| Jun 30, 2024 | -14.60% |
| Mar 31, 2024 | -17.98% |